IL-6 enhances the generation of cytolytic T lymphocytes in the allogeneic mixed leucocyte reaction
- 1 July 1992
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 89 (1) , 148-153
- https://doi.org/10.1111/j.1365-2249.1992.tb06894.x
Abstract
SUMMARY: Cytolytic T lymphocytes (CTL) require soluble proteins termed lymphokines to develop lytic activity. In this report we have studied two of the lymphokines involved in the development of CTL during the allogeneic mixed leucocyte reaction (MLR). High doses of dendritic cells induced lytic activity from purified CD8+ cells in both the murine and human MLR. Under these conditions, IL-2 and IL-6 were endogenously produced and secreted. Antibodies to IL-2 or the IL-2 receptor blocked CTL formation; however, anti-IL-6 receptor antibodies only partially inhibited the response while anti-IL-6 antibodies were largely ineffective. When limiting numbers of antigen-presenting cells were used CTL failed to develop, and neither IL-2 nor IL-6 was secreted into the culture supernatant. Although the addition of IL-6 to such cultures was ineffective in generating CTL, the combination of IL-2 and IL-6 resulted in a 4-5-fold increase in lytic activity over that of IL-2 alone. We conclude that in the allogeneic MLR, IL-2 and IL-6 contribute to the generation of lytically active CD8+ cells, and the effect of IL-6 is evident when the dose of antigen-presenting cell is limited.Keywords
This publication has 24 references indexed in Scilit:
- Distinctive features in the production of IL-6 by human T cellsCellular Immunology, 1990
- Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells.The Journal of Experimental Medicine, 1990
- Accessory factors involved in murine T cell activation. Distinct roles of interleukin 6, interleukin 1 and tumor necrosis factorEuropean Journal of Immunology, 1990
- The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymusCellular Immunology, 1989
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Synergistic activation of human t cells by interleukin 1 and interleukin 6European Journal of Immunology, 1988
- T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor.The Journal of Experimental Medicine, 1988
- B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes.The Journal of Experimental Medicine, 1988
- Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells.The Journal of Experimental Medicine, 1987
- Interleukin-HP1, a T cell-derived hybridoma growth factor that supports the in vitro growth of murine plasmacytomas.The Journal of Experimental Medicine, 1987